5431 related articles for article (PubMed ID: 3402430)
1. c-myc down-regulates class I HLA expression in human melanomas.
Versteeg R; Noordermeer IA; Krüse-Wolters M; Ruiter DJ; Schrier PI
EMBO J; 1988 Apr; 7(4):1023-9. PubMed ID: 3402430
[TBL] [Abstract][Full Text] [Related]
2. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
Versteeg R; Krüse-Wolters KM; Plomp AC; van Leeuwen A; Stam NJ; Ploegh HL; Ruiter DJ; Schrier PI
J Exp Med; 1989 Sep; 170(3):621-35. PubMed ID: 2788705
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.
Peltenburg LT; Dee R; Schrier PI
Nucleic Acids Res; 1993 Mar; 21(5):1179-85. PubMed ID: 8464702
[TBL] [Abstract][Full Text] [Related]
4. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
Schrier PI; Versteeg R; Peltenburg LT; Plomp AC; van 't Veer LJ; Krüse-Wolters KM
Semin Cancer Biol; 1991 Feb; 2(1):73-83. PubMed ID: 1912519
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
9. Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines.
Griffioen M; Ouwerkerk IJ; Harten V; Gobin SJ; van den Elsen PJ; Schrier PI
Immunogenetics; 1999 Apr; 49(4):287-94. PubMed ID: 10079292
[TBL] [Abstract][Full Text] [Related]
10. C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity.
Grover R; Ross DA; Richman PI; Robinson B; Wilson GD
Eur J Surg Oncol; 1996 Aug; 22(4):342-6. PubMed ID: 8783648
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
Wang Z; Margulies L; Hicklin DJ; Ferrone S
Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
[TBL] [Abstract][Full Text] [Related]
13. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
[TBL] [Abstract][Full Text] [Related]
14. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
Peltenburg LT; Schrier PI
Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
[TBL] [Abstract][Full Text] [Related]
16. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of MHC class II genes in lung tumour cell lines.
Redondo M; Ruiz-Cabello F; Concha A; Hortas ML; Serrano A; Morell M; Garrido F
Eur J Immunogenet; 1998 Dec; 25(6):385-91. PubMed ID: 9949943
[TBL] [Abstract][Full Text] [Related]
19. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.
Pende D; Accame L; Pareti L; Mazzocchi A; Moretta A; Parmiani G; Moretta L
Eur J Immunol; 1998 Aug; 28(8):2384-94. PubMed ID: 9710216
[TBL] [Abstract][Full Text] [Related]
20. Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc-transformed U-937 monoblasts.
Larsson LG; Oberg F; Stöckbauer P; Masucci MG; Nilsson K
Int J Cancer; 1992 Nov; 52(5):759-65. PubMed ID: 1358827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
